Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

China Biologic Products Holdings Inc (NASDAQ:CBPO)

91.51
Delayed Data
As of 12:55pm ET
 +0.70 / +0.77%
Today’s Change
88.25
Today|||52-Week Range
126.47
-14.89%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$2.5B

Company Description

China Biologic Products Holdings, Inc. manufactures and distributes plasma-based pharmaceutical products and other biological substances. Its products include human albumin, human immunoglobulin for intravenous injection, human Hepatitis B immunoglobulin, human rabies immunoglobulin, human immunoglobulin, human coagulation factor VIII, human prothrombin complex concentrate, and placenta polypeptide. The company was founded on December 20, 1989 and is headquartered in Beijing, China.

Contact Information

China Biologic Products Holdings, Inc.
Jialong International Building
Beijing Beijing 100125
P:861065983111
Investor Relations:
861065983099

Employees

Shareholders

Mutual fund holders47.72%
Other institutional31.28%
Individual stakeholders--

Top Executives

Xiao Ying GaoChairman & Chief Executive Officer
Ming YangChief Financial & Accounting Officer